Akoya

官网网址：https://www.akoyabio.com/

Unmet Need in Cancer Immunotherapy

Despite the progress we’ve made in cancer immunotherapy, response rates continue to remain in the 20 to 30% range. There’s a need for biomarkers that can accurately predict response to treatment.

Understanding Cancer-Immune Biology

Immunotherapy treatments rely on the activation of the immune system to fight and kill tumor cells. The key to understanding more about tumor-immune biology lies in studying the complexity of the tumor microenvironment.

Transforming Your Approach to Cancer Biomarker Discovery

Multispectral Imaging enables the discovery of biomarker signatures from a single FFPE tissue section, while preserving the spatial context of the tumor microenvironment.

Visualize

See how cells organize and interact in the tumor microenvironment

Quantify

Shift the paradigm from subjective IHC measurements to quantitative, reproducible multiplex imaging

Predict

Reliably predict immunotherapy response and disease progression through novel biomarker signatures